Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

NCT00630630 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Levetiracetam
OTHER: Placebo

Sponsor

UCB Pharma